VYOME HOLDINGS, INC. Number of Reportable Segments
VYOME HOLDINGS, INC. (HIND) reported Number of Reportable Segments of 2 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-12
- VYOME HOLDINGS, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- VYOME HOLDINGS, INC. number of reportable segments for fiscal 2024 was 1.00 segment.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-20 | ||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-04-04 |
segments
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-03-31 | 2.00 segments 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 2.00 segments 10-K · filed 2026-03-18 |
Segment
| Period end | Number of Reportable Segments 6 month |
|---|---|
| 2026-06-30 | 2.00 Segment 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |